Company / Shareholders' Equity
Minerva Neurosciences, Inc. Shareholders' Equity History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$25.7M
FY2024
5-year range
-$25.7M / $52.7M
FY2020-FY2024
Trend
-28.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Minerva Neurosciences, Inc. reports negative total equity of -$26M in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$26M in FY2024.
Declined from $8M to -$26M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Minerva Neurosciences, Inc.'s shareholders' equity has declined for 3 consecutive years.
- In FY2024, shareholders' equity decreased 28.3% year-over-year.
- Peak shareholders' equity was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$25.7M | -28.3% |
| FY2023 | -$20.0M | -351.1% |
| FY2022 | $8.0M | -84.9% |
| FY2021 | $52.7M | +89.6% |
| FY2020 | $27.8M | -69.2% |
| FY2019 | $90.3M | -31.4% |
| FY2018 | $131.6M | +24.2% |
| FY2017 | $106.0M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026